Allergy Therapeutics Plc is a biotechnology company. It focuses on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. Its broad pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. It operates through the following geographical segments: Central Europe, Southern Europe, the United Kingdom, and the Rest of the World. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.